… alone or in combination with dendritic cells (DCs). Other … A clinical trial which combined a
mutant RAS peptide vaccine with … therapy consisting of tumor lysate-pulsed DCs and CIKs after …

… Dendritic cell (DC) vaccines utilize DCs loaded with tumor antigens ex vivo or transfected to
… clinical trials of melanoma and prostate cancer (52), are commonly studied in CRC as well. …

… , such as cytokine-induced killer (CIK), dendritic cell vaccine (DCV), or dendritic cell-cytokine…
immunotherapy for refractory lymphoblastic leukemia (4) and metastatic melanoma (5). …

… This study evaluated cellular immune function and efficacy before and after DC-CIK … in
patients with colorectal cancer and further confirmed the efficacy and safety of adoptive cellular …

… In melanoma patients immature and mature MoDC preps were compared … metastatic
colorectal cancer, a small, randomized phase I DC vaccine trial randomized tumor lysate pulsed …

… the staging of patients with AGC (28). In this study we have continuously validated the
patient allocation design termed as the prospective patient's preference-based study (PPPS) in …

… and dendritic cell (DC)-based vaccines. Table 1 summarizes … the function of autologous
tumor lysate-pulsed DCs in boosting … NSCLC, melanoma, GC, renal cell carcinoma, head and …

… dendritic cell (DC) vaccines used to treat 35 patients with melanoma. We showed that
checkpoint molecules induced by ex vivo maturation correlated with in vivo DC vaccine activity. …

… , it was demonstrated that one in every four to five patients with melanoma, renal cell carcinoma…
Dendritic cell (DC) vaccines are most frequently created by pulsing DCs with autologous …

… ) carried out preclinical studies on murine colorectal tumor by combining … Vaccination of
pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells …